Kush Andrew sold $362K of HCSG
Kush Andrew (EVP & Chief Operating Officer) sold 15,598 shares of HEALTHCARE SERVICES GROUP INC (HCSG) at $23.24 ($0.36M total) on 2026-08-04.
HEALTHCARE SERVICES GROUP INC
No enriched coverage for $HCSG in the last 7 days.
Kush Andrew (EVP & Chief Operating Officer) sold 15,598 shares of HEALTHCARE SERVICES GROUP INC (HCSG) at $23.24 ($0.36M total) on 2026-08-04.
ICICI Securities and Motilal Oswal reiterated ‘Buy’ ratings on Sagility India Ltd after the company reported a stronger-than-estimated Q1FY27, with resilient margins despite wage cost pressure. ICICI raised its target to ₹54 (about 31% upside), citing 15.2% YoY revenue growth and 23.8% EBITDA margin. Motilal set ₹57 (about 38% upside) after INR revenue, EBITDA and PAT beats, and expects FY27 normalization.
Healthcare Services Group (HCSG) reported Q2 results supported by steady occupancy, a recovered workforce, lower bad debt expense, and contractual pass-through of food and wage inflation. Management reaffirmed 2026 mid-single-digit revenue growth, projecting Q3 revenue of $475M to $485M, and a $75M share repurchase target.
Recent HCSG coverage spans financial news, earnings and insider activity.
In the last 30 days, HCSG insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($362K). The most active reporter was Kush Andrew, EVP & Chief Operating Officer, with 1 filing.
The filing signals insider selling by a senior executive, but it is not tied to a 10b5-1 plan and provides limited fundamental information.
ICICI Securities and Motilal Oswal reiterated ‘Buy’ ratings on Sagility India Ltd after the company reported a stronger-than-estimated Q1FY27, with resilient margins despite wage cost pressure. ICICI raised its target to ₹54 (about 31% upside), citing 15.2% YoY revenue growth and 23.8% EBITDA margin. Motilal set ₹57 (about 38% upside) after INR revenue, EBITDA and PAT beats, and expects FY27 normalization.
Guidance and cost targets provide a near-term earnings model update, with upside tied to a 2H ramp and downside risk from lumpy insurance/actuarial items and Genesis bankruptcy timing.
A modest EPS beat can matter for valuation-sensitive healthcare services names, but the article provides no additional drivers.
Profitability returned in Q2 and management reiterated a mid-single-digit 2026 growth outlook, supporting the current growth narrative.
alphai scores every news story that mentions HCSG with an AI model for sentiment and relevance, and aggregates insider trades from HEALTHCARE SERVICES GROUP INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Kush Andrew (EVP & Chief Operating Officer) sold 15,598 shares of HEALTHCARE SERVICES GROUP INC (HCSG) at $23.24 ($0.36M total) on 2026-08-04.
1 min readICICI Securities and Motilal Oswal reiterated ‘Buy’ ratings on Sagility India Ltd after the company reported a stronger-than-estimated Q1FY27, with resilient margins despite wage cost pressure. ICICI raised its target to ₹54 (about 31% upside), citing 15.2% YoY revenue growth and 23.8% EBITDA margin. Motilal set ₹57 (about 38% upside) after INR revenue, EBITDA and PAT beats, and expects FY27 normalization.
5 min readHealthcare Services Group (HCSG) reported Q2 results supported by steady occupancy, a recovered workforce, lower bad debt expense, and contractual pass-through of food and wage inflation. Management reaffirmed 2026 mid-single-digit revenue growth, projecting Q3 revenue of $475M to $485M, and a $75M share repurchase target.
7 min readThe article says more than 100 companies reported quarterly earnings during peak Q2 season, with results described as resilient despite macro uncertainty. It cites FactSet research that about 75% of companies on a major index beat estimates, but only ~25% by more than 10%. It lists specific beats, including Alphabet (GOOG) EPS $9.11 vs $6.22 expected, and Southwest (LUV) EPS $0.94 vs $0.42.
7 min readHealthcare Services Group (HCSG) reported Q2 net income of $22.70 million versus a $32.37 million loss a year earlier, with EPS of $0.32 versus a $0.44 loss. Revenue rose to $470.81 million from $458.49 million. Adjusted EBITDA was $35.59 million versus an EBITDA loss of $36.32 million. The company reaffirmed a 2026 mid-single-digit growth outlook.
2 min readHEALTHCARE SERVICES GROUP INC (HCSG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-2026xq2xpressrelease.htm EX-99.1 Document Exhibit 99.1 Healthcare Services Group Reports Second Quarter Results Delivers Strong Results Reaffirms 2026 Growth Outlook • Revenue of $470.8 million. • Net income and diluted EPS of $22.7 million and $0.32. • Cash flow f
4 min readCraneware, a London AIM-listed healthcare cost management software firm, said it suffered a cyberattack involving unauthorized access to part of its data environment. It reported that a significant volume of file names were viewed and exfiltrated, including employee data and some customer and partner records, and it notified the US FBI and UK ICO. Shares fell up to 8.9% to 1,106p; Peel Hunt put its buy and target under review.
4 min readSpire Healthcare said it became Team GB’s exclusive Official Healthcare Services Partner through end-2028, including the Los Angeles 2028 Olympics. The deal covers marketing and campaigns using Spire’s UK network of 38 hospitals and 60+ clinics. Spire reported treating 1.36 million patients in 2025 and is listed on the LSE (FTSE 250).
2 min readHealthcare Services Group, Inc. (NASDAQ: HCSG) has extended its $300 million credit facility to April 7, 2031, through a Second Amendment to its existing Credit Agreement. This amendment, dated April 7, 2026, also integrates a daily SOFR interest rate option. All other terms of the original Credit Agreement remain in effect.
2 min readHillsdale Investment Management Inc. increased its stake in Healthcare Services Group (NASDAQ:HCSG) by 22.6%, purchasing an additional 81,670 shares to a total of 443,310 shares valued at approximately $7.46 million. This comes amidst reports of Healthcare Services Group beating Q4 earnings expectations with $0.44 EPS versus a $0.23 consensus, alongside a 6.6% year-over-year revenue growth. However, the company also saw significant insider selling, with two EVPs offloading substantial portions of their holdings totaling about 144,472 shares in the past three months.
3 min read